Neuraceq (Piramal Imaging, SA)
Welcome to the PulseAid listing for the Neuraceq drug offered from Piramal Imaging, SA. This Radioactive Diagnostic Agent [EPC],Positron Emitting Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Piramal Imaging, SA |
| NON-PROPRIETARY NAME: | florbetaben F 18 |
| SUBSTANCE NAME: | FLORBETABEN F-18 |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Radioactive Diagnostic Agent [EPC],Positron Emitting Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-03-20 |
| END MARKETING DATE: | 0000-00-00 |
Neuraceq HUMAN PRESCRIPTION DRUG Details:
| Item Description | Neuraceq from Piramal Imaging, SA |
| LABELER NAME: | Piramal Imaging, SA |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 135(mCi/mL) |
| START MARKETING DATE: | 2014-03-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 54828-001_859249bf-a0c1-40fd-af5c-a831c07c1b9a |
| PRODUCT NDC: | 54828-001 |
| APPLICATION NUMBER: | NDA204677 |
Other FLORBETABEN F-18 Pharmaceutical Manufacturers / Labelers:
